Company genXone S.A.

Equities

GX1

PLGENXN00013

Pharmaceuticals

End-of-day quote Warsaw S.E. 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
6 PLN +1.69% Intraday chart for genXone S.A. -1.64% +11.52%

Business Summary

Genxone SA is a Poland-based company, which specializes in NGS (next generation sequencing) and medical diagnostics. The Company is involved in the development and marketing of nanoforming technology in the field of science, business and medicine and cooperates as a commercial partner with Oxford Nanopore Technologies - biotechnological innovation entity.

Number of employees: 20

Sales per Business

PLN in Million2022Weight2023Weight Delta
Nucleic Acid Sequencing Services
100.0 %
11 100.0 % 2 100.0 % -77.38%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
73.3 %
5 49.5 % 2 73.3 % -66.52%
International
26.7 %
5 50.5 % 1 26.7 % -88.05%

Managers

Managers TitleAgeSince
Chief Executive Officer - 15-12-31
Chief Operating Officer - 15-12-31
Chief Tech/Sci/R&D Officer - 17-12-31
Director/Board Member - -
Corporate Officer/Principal - 02-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 59 -
Director/Board Member 59 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,296,600 1,535,992 ( 46.59 %) 0 46.59 %

Company contact information

GenXone SA

ul. Kobaltowa 6 Zlotniki

62-002, Suchy Las

+48 888 60 23 08

http://www.genxone.eu
address genXone S.A.(GX1)